For citation:
Derkach E.V., Pyadushkina E.A., Avxentyeva M.V., Boyarskaya T.V., Yagnenkova E.E., Mokrova A.S., Maryanyan M.M. The use of various genetically engineered biological drugs and selective immunosuppressants within the current provider-payment model of russian diagnosis-related groups. FARMAKOEKONOMIKA. Modern Pharmacoeconomic and Pharmacoepidemiology. 2020;13(3):225-239. (In Russ.) https://doi.org/10.17749/2070-4909/farmakoekonomika.2020.058

This work is licensed under a Creative Commons Attribution-NonCommercial-ShareAlike 4.0 International License.